We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals

34 hedge funds and large institutions have $89M invested in Eledon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

515% more capital inflows, than outflows

Capital inflows: $45.8M | Capital outflows: $7.45M

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

62% more funds holding

Funds holding: 21 → 34 (+13)

58.13% more ownership

Funds ownership: 0% → 58.13% (+58%)

Holders
34
Holders Change
+13
Holders Change %
+61.9%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
5
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ELDN Hedge Fund Activity: Q1 2021 in Review

34 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q1 2021, worth a combined $89M — up 0.67% from $88.4M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ELDN positions and 6 closed out — a net gain of 13 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $16.8M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.58M sold.

  • 34 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q1 2021, up from 21 in Q4 2020.
  • Funds reported $89M of Eledon Pharmaceuticals stock for Q1 2021, up 0.67% quarter-over-quarter.
  • 19 funds opened new Eledon Pharmaceuticals positions in Q1 2021 and 6 closed out, a net change of +13 holders.
  • The largest Eledon Pharmaceuticals buyer in Q1 2021 was EcoR1 Capital, an estimated $16.8M added.
  • The largest Eledon Pharmaceuticals seller in Q1 2021 was Stonepine Capital Management, an estimated $2.58M sold.

Based on aggregated 13F filings for Q1 2021.